Dianthus Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 04/08/2026 | Mar 2026Filed 04/08/2026 | Sep 2025Filed 05/11/2025 | Jun 2025Filed 04/08/2026 | Mar 2025Filed 04/08/2026 | Sep 2024Filed 05/11/2025 | Jun 2024Filed 05/11/2025 | Mar 2024Filed 05/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $12 | $6.3 | $0.4 | $0.2 | $1.2 | $2.2 | $1.9 | $0.9 | |
| −$50 | −$41 | −$37 | −$32 | −$30 | −$25 | −$18 | −$14 | |
| −$0.90 | −$0.85 | −$0.97 | −$0.88 | −$0.82 | −$0.74 | −$0.51 | −$0.54 | |
| 56 | 48 | 38 | 36 | 36 | 34 | 34 | 26 |
Trend